YAQUELIN QUINTERO: Open Payments
NPI 1629379458 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,639 in 144 payments from 20 companies in 2025. Trend: 2023 $2,419 · 2024 $2,417 · 2025 $3,639
Food & beverage: $3,556Education: $83
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $542 |
| Arcutis Biotherapeutics, Inc. | 22 | $401 |
| UCB, Inc. | 8 | $376 |
| GENZYME CORPORATION | 9 | $293 |
| Hill Dermaceuticals, Inc. | 1 | $278 |
| Regeneron Healthcare Solutions, Inc. | 5 | $249 |
| Botanix SB Inc | 6 | $221 |
| LEO Pharma Inc. | 13 | $218 |
| Galderma Laboratories, L.P. | 15 | $187 |
| Lilly USA, LLC | 7 | $167 |
Products named: DUPIXENT, Zoryve, Bimzelx, Tolak, SKYRIZI, SOFDRA, RINVOQ, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
